ESR1 and breast cancer: HNF1A, ESR1, and FLT4 were mutated significantly more frequently in tumor tissue samples obtained from patients with stage III BC, while SYNE1, PER1, and LRP1B were mutated significantly more frequently in stage IV BC (Table 3).